What is Jinghua Pharmaceutical Group Co., Ltd.'s (002349.SZ) StockRank?

MoatMap's StockRank for Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) is 85/100, with a Strong Buy signal. This is a composite score combining Quality (75), Value (47), and Momentum (51) factor ranks across MoatMap's 19,000+ stock universe.

Does Jinghua Pharmaceutical Group Co., Ltd. have an economic moat?

Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Jinghua Pharmaceutical Group Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) is Strong Buy, based on a StockRank of 85/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Jinghua Pharmaceutical Group Co., Ltd. in?

Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002349.SZ

STRONG BUYREMOVE

Jinghua Pharmaceutical Group Co., Ltd. · Healthcare · China · $866M · Avg Vol: $9M/d

StockRank

P/E (TTM)

24.1x

ROE

8.7%

D/E

0.0x

Dividend %

1.4%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Jinghua Pharmaceutical lacks the global regulatory validation, scale, and advanced biologics capabilities required to benefit from the high-conviction CDMO pricing power cycle.

COMPANY DESCRIPTION

Jinghua Pharmaceutical Group Co., Ltd. manufactures Traditional Chinese Medicines (TCM), chemical active pharmaceutical ingredients (APIs), and finished formulations. The company's competitive moat is anchored by its proprietary, national-level protected TCM formulas, such as Wangshi Baochi Wan and Jideji Sheyao, which enjoy strong brand heritage and pricing power. It is a specialized pharmaceutical player with a balanced portfolio of traditional remedies and modern chemical APIs.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	232M	223M	207M	216M	-2.5%
EPS	0.04	0.04	0.04	0.04	0.9%
Shares	814M	814M	814M	830M	+1.9%
Debt	3M	3M	2M	557,671	-45.0%
Equity	355M	361M	382M	407M	4.7%
Op CF	53M	43M	46M	50M	-1.7%
Inv CF	16M	-31M	-16M	-69M	—
Fin CF	-27M	-14M	-16M	-5M	—

PRICE (1M)-14.8%

SMA 50SMA 200

$0.95

RSI (14)

29.8

52W High

$1.23

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

9.6%72.4

ROE

8.7%68.5

GP/Assets

21.6%49.7

Op. Margin

24.4%87.8

FCF/Assets

6.9%78.4

Piotroski

—83.5

Int. Cover

50.0x91.4

D/E Ratio

0.00x96.5

Current Ratio

5.54x73.6

Value

P/E (TTM)

24.1x47.4

EV/EBITDA

12.4x34.9

P/FCF

161.3x53.1

P/B

1.9x57.9

P/S

3.7x50.2

Div Yield

1.4%38.0

Momentum

52W High %

77%69.4

RS 6M

-28%45.0

SMA 50/200

0.96x51.9

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—38.1

Q Growth

6%46.7

FUNDAMENTALS

Market Cap

$866M

P/E (Forward)

19.1x

Gross Margin

52.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002349.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002349.SZ	Jinghua Pharmaceutical Group Co., Ltd.(you)	$866M	85	STRONG BUY
002390.SZ	Guizhou Xinbang Pharmaceutical Co., Ltd.	$870M	81	STRONG BUY
603367.SS	Cisen Pharmaceutical Co., Ltd.	$934M	81	STRONG BUY
600976.SS	Jianmin Pharmaceutical Group Co.,Ltd.	$690M	87	STRONG BUY
002737.SZ	Sunflower Pharmaceutical Group Co.,Ltd	$1.1B	89	STRONG BUY
002332.SZ	Zhejiang Xianju Pharmaceutical Co.,Ltd.	$1.2B	87	STRONG BUY
000989.SZ	Jiuzhitang Co., Ltd.	$1.0B	91	STRONG BUY
9989.HK	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	$773M	93	STRONG BUY
002393.SZ	Tianjin Lisheng Pharmaceutical Co.,Ltd.	$679M	90	STRONG BUY
603676.SS	Tibet Weixinkang Medicine Co., Ltd.	$594M	83	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) — Stock Score Summary

Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) has a MoatMap StockRank of 85/100 based on Quality (75/100), Value (47/100), and Momentum (51/100) factor scores. The current signal is STRONG BUY. Jinghua Pharmaceutical lacks the global regulatory validation, scale, and advanced biologics capabilities required to benefit from the high-conviction CDMO pricing power cycle.

Key Financial Metrics

Price	$0.95
Market Cap	$866M
P/E (TTM)	24.11
P/E (Forward)	19.15
Price/Book	1.88
Return on Equity	8.7%
Return on Invested Capital	9.6%
Debt/Equity	0.16
Gross Margin	52.1%
Operating Margin	24.4%
Revenue Growth	4.5%
Dividend Yield	1.4%
Free Cash Flow	$5M

Jinghua Pharmaceutical Group Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Jinghua Pharmaceutical Group Co., Ltd.’s (002349.SZ) StockRank?: MoatMap’s StockRank for Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) is 85/100, with a Strong Buy signal. It is a composite of Quality (75), Value (47), and Momentum (51) factor ranks across MoatMap’s 19,000+ stock universe.
Does Jinghua Pharmaceutical Group Co., Ltd. have an economic moat?: Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jinghua Pharmaceutical Group Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) is Strong Buy, based on a StockRank of 85/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jinghua Pharmaceutical Group Co., Ltd. in?: Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).